SLC6A5 and amyotrophic lateral sclerosis: We found that GAD65 punctae on the MN body were decreased by more than 50% (Figures 4D and 4E) and the glycine transporter 2 (GLYT2) punctae by about 20% (Figures 4F and 4G) compared with sALS with non-ALS groups.